Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Deborah T Weiss"'
Autor:
Jonathan S Wall, Stephen J Kennel, Tina eRichey, Amy eAllen, Alan eStuckey, Deborah T Weiss, Sallie D Macy, Robin eBarbour, Peter eSeubert, Alan eSolomon, Dale eSchenk
Publikováno v:
Frontiers in Immunology, Vol 2 (2011)
AA amyloidosis results from the pathologic deposition in the kidneys and other organs of fibrils composed of N-terminal fragments of serum amyloid A protein (SAA). Given that there are only limited means to visualize these deposits, we have developed
Externí odkaz:
https://doaj.org/article/7cfe2d04166f4f87bcc8dde5821b273f
Autor:
Sanjay Phogat, Song Ding, Robert Parks, Raphael Gottardo, Lindsey Galmin, Kathryn E. Foulds, Guido Ferrari, Karen V. Kibler, Steve Self, Beatriz Perdiguero, Sherry Stanfield-Oakley, Nicole L. Yates, Deborah T. Weiss, Jonathan L. Heeney, Mariano Esteban, David C. Montefiori, Michael S. Seaman, Benedikt Asbach, Giuseppe Pantaleo, Donald N. Forthal, Bertram L. Jacobs, Mario Roederer, Georgia D. Tomaras, James Tartaglia, Juan García-Arriaza, Anthony D. Cristillo, Ralf Wagner, Susan W. Barnett
Publikováno v:
Journal of Virology. 93
Author(s): Kibler, Karen V; Asbach, Benedikt; Perdiguero, Beatriz; Garcia-Arriaza, Juan; Yates, Nicole L; Parks, Robert; Stanfield-Oakley, Sherry; Ferrari, Guido; Montefiori, David C; Tomaras, Georgia D; Roederer, Mario; Foulds, Kathryn E; Forthal, D
Autor:
B. H. Oakes, Thierry Calandra, Chelsey Bennett, Kathryn E. Foulds, Ralf Wagner, Matthieu Perreau, Mark Parrington, Annette Ives, J. McElrath, Konstantin V. Pugachev, Bertram L. Jacobs, Thierry Roger, Georgia D. Tomaras, Mariano Esteban, Guido Ferrari, Nicole L. Yates, David C. Montefiori, Harold Kleanthous, Mario Roederer, Bryan T. Mayer, Karen V. Kibler, Giuseppe Pantaleo, S. Ding, M. Vaine, Sanjay Phogat, Benedikt Asbach, Beatriz Perdiguero, Shing Fen Kao, Deborah T. Weiss, A. G. Spies, Gregory J. Mize, Jim Tartaglia, Raphael Gottardo, Maryann Giel-Moloney
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Scientific reports, vol. 9, no. 1, pp. 20005
Scientific Reports
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Scientific reports, vol. 9, no. 1, pp. 20005
Scientific Reports
Digital.CSIC. Repositorio Institucional del CSIC
instname
Multiple approaches utilizing viral and DNA vectors have shown promise in the development of an effective vaccine against HIV. In this study, an alternative replication-defective flavivirus vector, RepliVax (RV), was evaluated for the delivery of HIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c440ba3a669e2a4c5a0e11f58f180f82
http://hdl.handle.net/10261/241086
http://hdl.handle.net/10261/241086
Autor:
Song Ding, Karen V. Kibler, Juan García-Arriaza, Anthony D. Cristillo, Benedikt Asbach, Ralf Wagner, Jonathan L. Heeney, James Tartaglia, Bertram L. Jacobs, Georgia D. Tomaras, Sherry Stanfield-Oakley, Guido Ferrari, Lindsey Galmin, Susan W. Barnett, Giuseppe Pantaleo, Steve Self, Michael S. Seaman, Raphael Gottardo, Deborah T. Weiss, Kathryn E. Foulds, Nicole L. Yates, Beatriz Perdiguero, Donald N. Forthal, Mariano Esteban, David C. Montefiori, Robert Parks, Sanjay Phogat, Mario Roederer
Publikováno v:
Journal of Virology
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Journal of virology, vol 93, iss 3
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC: Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Journal of virology, vol 93, iss 3
Digital.CSIC. Repositorio Institucional del CSIC
instname
© 2019 Kibler et al.
As part of the continuing effort to develop an effective HIV vaccine, we generated a poxviral vaccine vector (previously described) designed to improve on the results of the RV144 phase III clinical trial. The construct, NY
As part of the continuing effort to develop an effective HIV vaccine, we generated a poxviral vaccine vector (previously described) designed to improve on the results of the RV144 phase III clinical trial. The construct, NY
Autor:
Jennifer Delgado, Sharon Orndorff, Amanda Strickland, Celia C. LaBranche, Maria Grazia Ferrari, Deborah T. Weiss, Punnee Pitisuttithum, Sorachai Nitayaphan, Jim Treece, Hemant K. Vyas, Agnès Laurence Chenine, Anthony Griffiths, Robert McLinden, Ruth M. Ruprecht, Hanna B. Scinto, Supachai Rerks-Ngarm, Sandeep Gupta, Merlin L. Robb, Siddappa N. Byrareddy, Swati Thorat, Ranajit Pal, Jerome H. Kim, Muhammad M. Mukhtar, Elizabeth Plake, Nelson L. Michael, David C. Montefiori
Publikováno v:
Journal of Virology. 92
The phase III RV144 human immunodeficiency virus (HIV) vaccine trial conducted in Thailand remains the only study to show efficacy in decreasing the HIV acquisition risk. In Thailand, circulating recombinant forms of HIV clade A/E (CRF01_AE) predomin
Autor:
Yves Levy, Rodolphe Thiébaut, Gerard Zurawski, Anthony D. Cristillo, Laura Richert, Andres M. Salazar, Lauren Hudacik, Sandra Zurawski, Aurélie Wiedemann, Monica Montes, Lindsey Galmin, Cécile Peltekian, Henri Bonnabau, Deborah T. Weiss, Christine Lacabaratz, Anne-Laure Flamar
Publikováno v:
PLoS ONE
PLoS ONE, 2018, 13 (11), pp.e0207794. ⟨10.1371/journal.pone.0207794⟩
PLoS ONE, Public Library of Science, 2018, 13 (11), pp.e0207794. ⟨10.1371/journal.pone.0207794⟩
PLoS ONE, Vol 13, Iss 11, p e0207794 (2018)
PLoS ONE, 2018, 13 (11), pp.e0207794. ⟨10.1371/journal.pone.0207794⟩
PLoS ONE, Public Library of Science, 2018, 13 (11), pp.e0207794. ⟨10.1371/journal.pone.0207794⟩
PLoS ONE, Vol 13, Iss 11, p e0207794 (2018)
International audience; HIV-1 infection can be controlled by anti-retroviral drug therapy, but this is a lifetime treatment and the virus remains latent and rapidly rebounds if therapy is stopped. HIV-1-infected individuals under this drug regimen ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecdf388aa838a871ab0ffa1235f5194
https://hal.science/hal-03160760
https://hal.science/hal-03160760
Autor:
Steve Self, Raphael Gottardo, Nicole L. Yates, Andres M. Salazar, Guido Ferrari, Yves Levy, Mario Roederer, Bertram L. Jacobs, Sandra Zurawski, Xuesong Yu, Gerard Zurawski, Christine Lacabaratz, Peter Klucar, Shing Fen Kao, Georgia D. Tomaras, Giuseppe Pantaleo, Celia C. LaBranche, Karen V. Kibler, Anthony D. Cristillo, Lindsey Galmin, William Fulp, Deborah T. Weiss, Sherry Stanfield-Oakley, Kathryn E. Foulds, Xiaoying Shen, David C. Montefiori, Zhiqing Wang, Alicia Sato
Publikováno v:
Journal of Virology. 91
We compared the HIV-1-specific immune responses generated by targeting HIV-1 envelope protein (Env gp140) to either CD40 or LOX-1, two endocytic receptors on dendritic cells (DCs), in rhesus macaques primed with a poxvirus vector (NYVAC-KC) expressin
Autor:
Coyne Cp, Seth H. Pincus, Dean H. Hamer, Gang Chen, Anderson Frank, Deborah T. Weiss, Victor Ghetie, Ellen S. Vitetta, Grace A. Maresh, James E. Robinson, Kejing Song, Shiu Lok Hu, David K. Worthylake, Patricia Polacino, John W. Marks, Michael G. Rosenblum, Hye Kyung Chung
Publikováno v:
Journal of Virology. 91
The envelope (Env) glycoprotein of HIV is expressed on the surface of productively infected cells and can be used as a target for cytotoxic immunoconjugates (ICs), in which cell-killing moieties, including toxins, drugs, or radionuclides, are chemica
Autor:
Anthony L. DeVico, Jennifer Schwartz, Johnathan Misamore, Ilia Prado, Deborah T. Weiss, Timothy R. Fouts, George K. Lewis, Anthony D. Cristillo, Robert C. Gallo, Maria Cecilia Huaman, Jesse Francis, Ranajit Pal
Publikováno v:
Clinical and vaccine immunology : CVI. 23(7)
A promising concept for human immunodeficiency virus (HIV) vaccines focuses immunity on the highly conserved transition state structures and epitopes that appear when the HIV glycoprotein gp120 binds to its receptor, CD4. We are developing chimeric a
Autor:
James S. Foster, Alan Solomon, Deborah T. Weiss, Charles T. Bruker, John W. Prenshaw, Stephen J. Kennel, Jonathan S. Wall, Daniel P. Kestler
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 2011, Iss 5, Pp 73-85 (2011)
Breast Cancer : Basic and Clinical Research
Breast Cancer: Basic and Clinical Research, Vol 5 (2011)
Breast Cancer : Basic and Clinical Research
Breast Cancer: Basic and Clinical Research, Vol 5 (2011)
We have posited that Odontogenic Ameloblast Associated Protein (ODAM) serves as a novel prognostic biomarker in breast cancer and now have investigated its potential role in regulating tumor growth and metastasis. Human breast cancer MDA-MB-231 cells